Preclinical characterization of a novel STING agonist, MK-1454

被引:0
|
作者
Cemerski, Saso [1 ]
Altman, Michael [1 ]
Bandi, Madhavi [1 ]
Chang, Wonsuk [2 ]
Chen, Yiping [1 ]
Cui, Long [1 ]
Cumming, Jared [1 ]
Dorosh, Lauren [1 ]
Flateland, Lauren [1 ]
Ma, Yanhong [1 ]
Javaid, Sarah [1 ]
Ho, Thu [3 ]
Kopinja, Johnny [1 ]
Laskey, Jason [1 ]
Minnihan, Ellen [1 ]
Price, Laura [3 ]
Mogg, Robin [3 ]
O'Donnell, Gregory [3 ]
Pan, Bo-Sheng [1 ]
Perera, Samanthi [1 ]
Piesvaux, Jennifer [1 ]
Presland, Jeremy [1 ]
Rakhilina, Larissa [1 ]
Schroeder, Gottfried [1 ]
Slavonic, Michael [1 ]
Smock, Steven [1 ]
Trotter, Benjamin Wesley [1 ]
Wyss, Daniel [2 ]
Zhao, Qing [4 ]
Zhao, Shuxia [1 ]
Sadekova, Svetlana [5 ]
Yu, Ying [5 ]
Khilnani, Anuradha [4 ]
Tse, Archie [4 ]
机构
[1] Merck Res Labs, Boston, MA USA
[2] Merck Res Labs, Kenilworth, NJ USA
[3] Merck Res Labs, West Point, PA USA
[4] Merck Res Labs, Rahway, NJ USA
[5] Merck Res Labs, Palo Alto, CA USA
来源
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O31
引用
收藏
页数:2
相关论文
empty
未找到相关数据